Linaprazan Impurity 2 | CAS 248920-23-2 - Request Quote
Linaprazan Impurity 2
| SZ CAT No: | SZ-L122006 |
| CAS No | 248920-23-2 |
| Mol.F. | C20H23N3O2 |
| Mol.Wt. |
337.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Linaprazan Impurity 2 is chemically Methyl 8-((2,6-dimethylbenzyl)amino)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylate. Linaprazan Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Linaprazan Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linaprazan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 248920-23-2
Purchase 248920-23-2
Order 248920-23-2
Enquire 248920-23-2
price of 248920-23-2
248920-23-2 Supplier
248920-23-2 Manufacturer
248920-23-2 Exporter
buy high quality Linaprazan Impurity 2
Purchase Linaprazan Impurity 2
Linaprazan Impurity 2 suppliers
Linaprazan Impurity 2 manufacturers
Linaprazan Impurity 2 price
Order Linaprazan Impurity 2
Enquire Linaprazan Impurity 2
Linaprazan Impurity 2 cost
Linaprazan Impurity 2 Supplier
Linaprazan Impurity 2 Distributor
Linaprazan Impurity 2 for Method Validation
Linaprazan Reference Standard
Linaprazan Impurity 2 for ANDA Filing
Linaprazan Impurity 2 for Forced Degradation Studies
Linaprazan Impurity 2 Identification Standards
Linaprazan Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.